Digestive and Liver Disease Gastroenterology

Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →